1 Market Overview of RNAi for Therapeutic 1.1 RNAi for Therapeutic Market Overview 1.1.1 RNAi for Therapeutic Product Scope 1.1.2 Market Status and Outlook 1.2 Global RNAi for Therapeutic Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global RNAi for Therapeutic Market Size by Region (2015-2026) 1.4 Global RNAi for Therapeutic Historic Market Size by Region (2015-2020) 1.5 Global RNAi for Therapeutic Market Size Forecast by Region (2021-2026) 1.6 Key Regions, RNAi for Therapeutic Market Size YoY Growth (2015-2026) 1.6.1 North America RNAi for Therapeutic Market Size YoY Growth (2015-2026) 1.6.2 Europe RNAi for Therapeutic Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific RNAi for Therapeutic Market Size YoY Growth (2015-2026) 1.6.4 Latin America RNAi for Therapeutic Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa RNAi for Therapeutic Market Size YoY Growth (2015-2026) 2 RNAi for Therapeutic Market Overview by Type 2.1 Global RNAi for Therapeutic Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global RNAi for Therapeutic Historic Market Size by Type (2015-2020) 2.3 Global RNAi for Therapeutic Forecasted Market Size by Type (2021-2026) 2.4 siRNA 2.5 miRNA 2.6 shRNA 3 RNAi for Therapeutic Market Overview by Application 3.1 Global RNAi for Therapeutic Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global RNAi for Therapeutic Historic Market Size by Application (2015-2020) 3.3 Global RNAi for Therapeutic Forecasted Market Size by Application (2021-2026) 3.4 Cancer 3.5 Cardiovascular 3.6 HBV 3.7 Other 4 Global RNAi for Therapeutic Competition Analysis by Players 4.1 Global RNAi for Therapeutic Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2019) 4.3 Date of Key Manufacturers Enter into RNAi for Therapeutic Market 4.4 Global Top Players RNAi for Therapeutic Headquarters and Area Served 4.5 Key Players RNAi for Therapeutic Product Solution and Service 4.6 Competitive Status 4.6.1 RNAi for Therapeutic Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Alnylam Pharmaceuticals 5.1.1 Alnylam Pharmaceuticals Profile 5.1.2 Alnylam Pharmaceuticals Main Business 5.1.3 Alnylam Pharmaceuticals Products, Services and Solutions 5.1.4 Alnylam Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.1.5 Alnylam Pharmaceuticals Recent Developments 5.2 Arbutus Biopharma (Tekmira) 5.2.1 Arbutus Biopharma (Tekmira) Profile 5.2.2 Arbutus Biopharma (Tekmira) Main Business and Company’s Total Revenue 5.2.3 Arbutus Biopharma (Tekmira) Products, Services and Solutions 5.2.4 Arbutus Biopharma (Tekmira) Revenue (US$ Million) (2015-2020) 5.2.5 Arbutus Biopharma (Tekmira) Recent Development and Reaction to Covid-19 5.3 Arrowhead 5.5.1 Arrowhead Profile 5.3.2 Arrowhead Main Business 5.3.3 Arrowhead Products, Services and Solutions 5.3.4 Arrowhead Revenue (US$ Million) & (2015-2020) 5.3.5 Dicerna Pharmaceuticals Recent Developments 5.4 Dicerna Pharmaceuticals 5.4.1 Dicerna Pharmaceuticals Profile 5.4.2 Dicerna Pharmaceuticals Main Business 5.4.3 Dicerna Pharmaceuticals Products, Services and Solutions 5.4.4 Dicerna Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.4.5 Dicerna Pharmaceuticals Recent Developments 5.5 Mirna Therapeutics 5.5.1 Mirna Therapeutics Profile 5.5.2 Mirna Therapeutics Main Business 5.5.3 Mirna Therapeutics Products, Services and Solutions 5.5.4 Mirna Therapeutics Revenue (US$ Million) & (2015-2020) 5.5.5 Mirna Therapeutics Recent Developments 5.6 Quark Pharmaceuticals 5.6.1 Quark Pharmaceuticals Profile 5.6.2 Quark Pharmaceuticals Main Business 5.6.3 Quark Pharmaceuticals Products, Services and Solutions 5.6.4 Quark Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.6.5 Quark Pharmaceuticals Recent Developments 5.7 RXi Pharmaceuticals 5.7.1 RXi Pharmaceuticals Profile 5.7.2 RXi Pharmaceuticals Main Business and Company’s Total Revenue 5.7.3 RXi Pharmaceuticals Products, Services and Solutions 5.7.4 RXi Pharmaceuticals Revenue (US$ Million) (2015-2020) 5.7.5 RXi Pharmaceuticals Recent Development and Reaction to Covid-19 5.8 Silence Therapeutics 5.8.1 Silence Therapeutics Profile 5.8.2 Silence Therapeutics Main Business 5.8.3 Silence Therapeutics Products, Services and Solutions 5.8.4 Silence Therapeutics Revenue (US$ Million) & (2015-2020) 5.8.5 Silence Therapeutics Recent Developments 5.9 Benitec Biopharma 5.9.1 Benitec Biopharma Profile 5.9.2 Benitec Biopharma Main Business 5.9.3 Benitec Biopharma Products, Services and Solutions 5.9.4 Benitec Biopharma Revenue (US$ Million) & (2015-2020) 5.9.5 Benitec Biopharma Recent Developments 5.10 miRagen Therapeutics 5.10.1 miRagen Therapeutics Profile 5.10.2 miRagen Therapeutics Main Business 5.10.3 miRagen Therapeutics Products, Services and Solutions 5.10.4 miRagen Therapeutics Revenue (US$ Million) & (2015-2020) 5.10.5 miRagen Therapeutics Recent Developments 5.11 Sylentis 5.11.1 Sylentis Profile 5.11.2 Sylentis Main Business 5.11.3 Sylentis Products, Services and Solutions 5.11.4 Sylentis Revenue (US$ Million) & (2015-2020) 5.11.5 Sylentis Recent Developments 5.12 Gradalis 5.12.1 Gradalis Profile 5.12.2 Gradalis Main Business 5.12.3 Gradalis Products, Services and Solutions 5.12.4 Gradalis Revenue (US$ Million) & (2015-2020) 5.12.5 Gradalis Recent Developments 5.13 Sirnaomics 5.13.1 Sirnaomics Profile 5.13.2 Sirnaomics Main Business 5.13.3 Sirnaomics Products, Services and Solutions 5.13.4 Sirnaomics Revenue (US$ Million) & (2015-2020) 5.13.5 Sirnaomics Recent Developments 5.14 Silenseed 5.14.1 Silenseed Profile 5.14.2 Silenseed Main Business 5.14.3 Silenseed Products, Services and Solutions 5.14.4 Silenseed Revenue (US$ Million) & (2015-2020) 5.14.5 Silenseed Recent Developments 6 North America 6.1 North America RNAi for Therapeutic Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe RNAi for Therapeutic Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific RNAi for Therapeutic Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America RNAi for Therapeutic Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa RNAi for Therapeutic Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 RNAi for Therapeutic Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market RNAi for Therapeutic Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global RNAi for Therapeutic Market Size by Region (2015-2020) (US$ Million) Table 3. Global RNAi for Therapeutic Market Size Share by Region (2015-2020) Table 4. Global RNAi for Therapeutic Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global RNAi for Therapeutic Forecasted Market Size Share by Region (2021-2026) Table 6. Global RNAi for Therapeutic Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global RNAi for Therapeutic Market Size by Type (2015-2020) (US$ Million) Table 8. Global RNAi for Therapeutic Revenue Market Share by Type (2015-2020) Table 9. Global RNAi for Therapeutic Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global RNAi for Therapeutic Revenue Market Share by Type (2021-2026) Table 11. Global RNAi for Therapeutic Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global RNAi for Therapeutic Market Size by Application (2015-2020) (US$ Million) Table 13. Global RNAi for Therapeutic Revenue Market Share by Application (2015-2020) Table 14. Global RNAi for Therapeutic Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global RNAi for Therapeutic Revenue Market Share by Application (2021-2026) Table 16. Global RNAi for Therapeutic Revenue (US$ Million) by Players (2015-2020) Table 17. Global RNAi for Therapeutic Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2019) Table 19. Date of Key Manufacturers Enter into RNAi for Therapeutic Market Table 20. Global RNAi for Therapeutic Top Players Headquarters and Area Served Table 21. RNAi for Therapeutic Product Solution and Service Table 22. Global RNAi for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Alnylam Pharmaceuticals Basic Information List Table 25. Alnylam Pharmaceuticals Description and Business Overview Table 26. Alnylam Pharmaceuticals RNAi for Therapeutic Products, Services and Solutions Table 27. Revenue (Million US$) in RNAi for Therapeutic Business of Alnylam Pharmaceuticals (2015-2020) Table 28. Alnylam Pharmaceuticals Recent Developments Table 29. Arbutus Biopharma (Tekmira) Basic Information List Table 30. Arbutus Biopharma (Tekmira) Description and Business Overview Table 31. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Products, Services and Solutions Table 32. Revenue (Million US$) in RNAi for Therapeutic Business of Arbutus Biopharma (Tekmira) (2015-2020) Table 33. Arbutus Biopharma (Tekmira) Recent Developments Table 34. Arrowhead Basic Information List Table 35. Arrowhead Description and Business Overview Table 36. Arrowhead RNAi for Therapeutic Products, Services and Solutions Table 37. Revenue (Million US$) in RNAi for Therapeutic Business of Arrowhead (2015-2020) Table 38. Arrowhead Recent Developments Table 39. Dicerna Pharmaceuticals Basic Information List Table 40. Dicerna Pharmaceuticals Description and Business Overview Table 41. Dicerna Pharmaceuticals RNAi for Therapeutic Products, Services and Solutions Table 42. Revenue (Million US$) in RNAi for Therapeutic Business of Dicerna Pharmaceuticals (2015-2020) Table 43. Dicerna Pharmaceuticals Recent Developments Table 44. Mirna Therapeutics Basic Information List Table 45. Mirna Therapeutics Description and Business Overview Table 46. Mirna Therapeutics RNAi for Therapeutic Products, Services and Solutions Table 47. Revenue (Million US$) in RNAi for Therapeutic Business of Mirna Therapeutics (2015-2020) Table 48. Mirna Therapeutics Recent Developments Table 49. Quark Pharmaceuticals Basic Information List Table 50. Quark Pharmaceuticals Description and Business Overview Table 51. Quark Pharmaceuticals RNAi for Therapeutic Products, Services and Solutions Table 52. Revenue (Million US$) in RNAi for Therapeutic Business of Quark Pharmaceuticals (2015-2020) Table 53. Quark Pharmaceuticals Recent Developments Table 54. RXi Pharmaceuticals Basic Information List Table 55. RXi Pharmaceuticals Description and Business Overview Table 56. RXi Pharmaceuticals RNAi for Therapeutic Products, Services and Solutions Table 57. Revenue (Million US$) in RNAi for Therapeutic Business of RXi Pharmaceuticals (2015-2020) Table 58. RXi Pharmaceuticals Recent Developments Table 59. Silence Therapeutics Basic Information List Table 60. Silence Therapeutics Description and Business Overview Table 61. Silence Therapeutics RNAi for Therapeutic Products, Services and Solutions Table 62. Revenue (Million US$) in RNAi for Therapeutic Business of Silence Therapeutics (2015-2020) Table 63. Silence Therapeutics Recent Developments Table 64. Benitec Biopharma Basic Information List Table 65. Benitec Biopharma Description and Business Overview Table 66. Benitec Biopharma RNAi for Therapeutic Products, Services and Solutions Table 67. Revenue (Million US$) in RNAi for Therapeutic Business of Benitec Biopharma (2015-2020) Table 68. Benitec Biopharma Recent Developments Table 69. miRagen Therapeutics Basic Information List Table 70. miRagen Therapeutics Description and Business Overview Table 71. miRagen Therapeutics RNAi for Therapeutic Products, Services and Solutions Table 72. Revenue (Million US$) in RNAi for Therapeutic Business of miRagen Therapeutics (2015-2020) Table 73. miRagen Therapeutics Recent Developments Table 74. Sylentis Basic Information List Table 75. Sylentis Description and Business Overview Table 76. Sylentis RNAi for Therapeutic Products, Services and Solutions Table 77. Revenue (Million US$) in RNAi for Therapeutic Business of Sylentis (2015-2020) Table 78. Sylentis Recent Developments Table 79. Gradalis Basic Information List Table 80. Gradalis Description and Business Overview Table 81. Gradalis RNAi for Therapeutic Products, Services and Solutions Table 82. Revenue (Million US$) in RNAi for Therapeutic Business of Gradalis (2015-2020) Table 83. Gradalis Recent Developments Table 84. Sirnaomics Basic Information List Table 85. Sirnaomics Description and Business Overview Table 86. Sirnaomics RNAi for Therapeutic Products, Services and Solutions Table 87. Revenue (Million US$) in RNAi for Therapeutic Business of Sirnaomics (2015-2020) Table 88. Sirnaomics Recent Developments Table 89. Silenseed Basic Information List Table 90. Silenseed Description and Business Overview Table 91. Silenseed RNAi for Therapeutic Products, Services and Solutions Table 92. Revenue (Million US$) in RNAi for Therapeutic Business of Silenseed (2015-2020) Table 93. Silenseed Recent Developments Table 94. North America RNAi for Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 95. North America RNAi for Therapeutic Market Size Share by Country (2015-2020) Table 96. Europe RNAi for Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 97. Europe RNAi for Therapeutic Market Size Share by Country (2015-2020) Table 98. Asia-Pacific RNAi for Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 99. Asia-Pacific RNAi for Therapeutic Market Size Share by Country (2015-2020) (US$ Million) Table 100. Latin America RNAi for Therapeutic Market Size by Country (2015-2020) & (US$ Million) Table 101. Latin America RNAi for Therapeutic Market Size Share by Country (2015-2020) (US$ Million) Table 102. Middle East & Africa RNAi for Therapeutic Market Size by Players (2015-2020) (US$ Million) Table 103. Middle East & Africa RNAi for Therapeutic Market Size Share by Players (2015-2020) (US$ Million) Table 104. RNAi for Therapeutic Market Trends Table 105. RNAi for Therapeutic Market Drivers Table 106. RNAi for Therapeutic Market Challenges Table 107. RNAi for Therapeutic Market Restriants Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global RNAi for Therapeutic Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global RNAi for Therapeutic Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global RNAi for Therapeutic Market Share by Regions: 2020 VS 2026 Figure 4. North America RNAi for Therapeutic Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe RNAi for Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific RNAi for Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America RNAi for Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa RNAi for Therapeutic Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global RNAi for Therapeutic Market Share by Type in 2020 & 2026 Figure 10. siRNA Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. miRNA Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. shRNA Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Global RNAi for Therapeutic Market Size Share by Application in 2020 & 2026 Figure 14. Cancer Market Size (US$ Million) YoY Growth (2015-2026) Figure 15. Cardiovascular Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. HBV Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players RNAi for Therapeutic Market Share in 2019 Figure 20. United States RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa RNAi for Therapeutic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation